Recognized standard
29701 First edition 2010-09-15
FDA recognition 18-10 · ISO · Nanotechnology
Key facts
| Recognition number | 18-10 |
|---|---|
| Designation | 29701 First edition 2010-09-15 |
| Title | Nanotechnologies - Endotoxin test on nanomaterial samples for in vitro systems - Limulus amebocyte lysate (LAL) test. |
| Standards developer | International Organization for Standardization |
| Specialty area | Nanotechnology |
| Date of entry | Jun 7, 2018 |
| Scope (excerpt) | This International Standard describes the application of a test using Limulus amebocyte lysate (LAL) reagent for the evaluation of nanomaterials intended for cell-based in vitro biological test systems. The test is suitable for use with nanomaterial samples dispersed in aqueous media, e.g. water… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: